Shemesh Ari, Sood Gitanjli, Blair Kyle, Margolin Edward
University of Toronto
All India Institute of Medical Sciences, Rishikesh, INDIA.
Leber hereditary optic neuropathy (LHON) is a rare mitochondrial disorder primarily affecting young males, causing sequential visual loss due to optic nerve degeneration. LHON's unique maternally inherited trait, linked to mitochondrial DNA (mtDNA) point mutations, impacts complex I subunit genes, particularly m.11778G.A>, m.3460G.A>, and m.14484T.C> mutations in about 90% of cases. Although these mutations are present, not all carriers manifest symptoms owing to variable tissue heteroplasmy. Genetic and environmental influences, X-linked genes, and immunological aspects contribute to the disease's varied onset and progression. LHON typically initiates painlessly in one eye, progressing to the second eye within a year, leading to profound visual impairment, color vision deficits, and central scotomas. Although fundus examinations aid diagnosis, their absence doesn't rule out LHON. Recent advancements like optical coherence tomography (OCT) contribute to a better understanding and staging of the disease. Management includes lifestyle adjustments, vitamin supplements, and the use of idebenone in the subacute phase, aiming for vision recovery. However, most cases endure irreversible visual loss, necessitating ongoing supportive care and genetic counseling for affected families.
Leber遗传性视神经病变(LHON)是一种罕见的线粒体疾病,主要影响年轻男性,由于视神经变性导致渐进性视力丧失。LHON独特的母系遗传特征与线粒体DNA(mtDNA)点突变有关,影响复合体I亚基基因,约90%的病例中存在m.11778G.A>、m.3460G.A>和m.14484T.C>突变。尽管存在这些突变,但由于组织异质性不同,并非所有携带者都会出现症状。遗传和环境影响、X连锁基因以及免疫因素都对该疾病的不同发病和进展有影响。LHON通常在一只眼睛中无痛起病,在一年内进展至另一只眼睛,导致严重视力损害、色觉缺陷和中心暗点。虽然眼底检查有助于诊断,但没有眼底改变并不能排除LHON。光学相干断层扫描(OCT)等最新进展有助于更好地理解和分期该疾病。治疗包括生活方式调整、维生素补充以及在亚急性期使用艾地苯醌,目标是恢复视力。然而,大多数病例会遭受不可逆的视力丧失,因此需要对受影响的家庭持续提供支持性护理和遗传咨询。